Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Generalised stunting of roots in an epileptic child: is long-term phenytoin therapy the cause?

Jindal G, Pandey RK, Kumar D.

BMJ Case Rep. 2012 Jul 3;2012. pii: bcr0320126042. doi: 10.1136/bcr-03-2012-6042.

2.

Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy.

Girgis SS, Staple PH, Miller WA, Sedransk N, Thompson T.

J Periodontol. 1980 Aug;51(8):474-82.

PMID:
6931209
3.

Latent osteomalacia in epileptic patients on anticonvulsants.

Christiansen C, Kristensen M, Rodbro P.

Br Med J. 1972 Sep 23;3(5829):738-9.

4.

Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India.

Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG.

Lancet. 1998 Jan 3;351(9095):19-23.

PMID:
9433424
5.

Cerebellar atrophy in an epileptic child: is it due to phenytoin?

Ahuja SR, Karande S, Kulkarni MV.

J Postgrad Med. 2000 Oct-Dec;46(4):278-9.

6.

Cerebellar volume and long-term use of phenytoin.

De Marcos FA, Ghizoni E, Kobayashi E, Li LM, Cendes F.

Seizure. 2003 Jul;12(5):312-5.

7.

Phenytoin as the first option in female epileptic patients?

Trevisol-Bittencourt PC, da Silva VR, Molinari MA, Troiano AR.

Arq Neuropsiquiatr. 1999 Sep;57(3B):784-6.

PMID:
10751912
8.

Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.

Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, Chen SD, Tan TY, Huang CR, Chan SH.

Epilepsia. 2012 Jan;53(1):120-8. doi: 10.1111/j.1528-1167.2011.03316.x. Epub 2011 Nov 15.

9.

Phenytoin induced severe disabling osteomalacia in a young male with seizure disorder.

Khaira A, Gupta A, Madhu SV, Khaira DD.

J Assoc Physicians India. 2008 May;56:376-8.

PMID:
18700645
10.

Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy.

Iivanainen M, Savolainen H.

Acta Neurol Scand Suppl. 1983;97:49-67.

PMID:
6424397
12.

Monitoring of drug therapy in epileptic children.

Singh LM, Mehta S, Vohra RM, Nain CK.

Int J Clin Pharmacol Ther Toxicol. 1987 May;25(5):251-4.

PMID:
3596850
13.

Peripheral neuropathy in children on long-term phenytoin therapy.

Mochizuki Y, Suyehiro Y, Tanizawa A, Ohkubo H, Motomura T.

Brain Dev. 1981;3(4):375-83.

PMID:
6274215
14.

The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.

Phabphal K, Geater A, Limapichart K, Sathirapanya P, Setthawatcharawanich S, Witeerungrot N, Thammakumpee N, Leelawattana R.

Epilepsia. 2013 Feb;54(2):249-55. doi: 10.1111/epi.12049. Epub 2013 Jan 2.

15.
16.

Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy.

Luoma PV, Reunanen MI, Sotaniemi EA.

Acta Med Scand. 1979;206(3):229-31.

PMID:
495231
17.

Management of phenytoin-induced gingival enlargement: a case report.

Parwani RN, Parwani SR.

Gen Dent. 2013 Sep-Oct;61(6):61-7.

PMID:
24064166
18.

[Temporal cerebellar atrophy following phenytoin therapy].

Guerrero AL, Paniagua JA, Díaz Cascajo P, Cacho J, Arias P, Martín JA.

Neurologia. 1997 Jun-Jul;12(6):259-61. Spanish.

PMID:
9303595
19.

Delayed eruption of secondary dentition associated with phenytoin therapy.

Appleton RE, Leach H.

Dev Med Child Neurol. 1991 Dec;33(12):1117-8. No abstract available.

PMID:
1778348
20.

Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial.

Christiansen C, Rodbro P, Nielsen CT.

Acta Paediatr Scand. 1975 Mar;64(2):219-24.

PMID:
1130178

Supplemental Content

Support Center